Intraoperative Neuromonitoring Market Share Analysis of The Top Industry Players, Growth Opportunities



    Global intraoperative neuromonitoring market is forecasted to reach around $5.5 billion by 2023.

    Press Release

    Amazon Music Disney Promo

    The growth in the market will be led by the ageing population, increasing prevalence of chronic disorders, applications of IONM in different surgeries, and risk management through IONM during complex surgeries.

    In terms of product and services, the intraoperative neuromonitoring market has been categorized into systems, instruments, and accessories. The systems segment was the largest contributor to the global market, with more than 45% share in 2016.

    On the basis of source type, the intraoperative neuromonitoring industry has been categorized insourced monitoring and outsourced monitoring. The insourced monitoring constituted more than 60% share of the intraoperative neuromonitoring market, globally. However, this share is expected to decrease during the forecast period due to the low maintenance cost associated with outsourced monitoring. Furthermore, the hospital has to provide training and other facilities to its IONM staff on a regular basis, which leads to additional expenses and is a tough task for the hospital.

    Request to Get the Sample Pages at:

    The IONM applications involve spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries. Among the available applications of IONM, orthopedic surgery is estimated to witness the fastest growth in demand at a CAGR of 7.9% during the forecast period. By end user, the intraoperative neuromonitoring market is led by hospitals contributing more than $2 billion in 2016. The large number of hospitals is the major factor to its large share in the market.

    Asia-Pacific is the potential intraoperative neuromonitoring market for the growth of due to the high population base, presence of unmet medical needs, and increasing disposable incomes of people in the region. Moreover, the medical tourism and technological advancements make Asia-Pacific a lucrative market for IONM. It is estimated that the APAC will witness the fastest growth in demand at a CAGR of 8.6% during the forecast period.

    Some of the other key players operating in the global intraoperative neuromonitoring market are Accurate Monitoring LLC, Computational Diagnostics, Inc., IntraNerve, LLC, Inomed Medizintechnik GmbH, Medtronic plc, and SpecialtyCare.